Table 1.
Socio-demographic characteristics of the sample.
| N = 221 | |
|---|---|
| ASENDHI | 74.20% (164/221) |
| Age (years) | 38.36 (10.74) |
| Sex | |
| Female | 73.30% (162/221) |
| Male | 26.29% (59/221) |
| BMI (kg/m2) | 29.65 (6.26) |
| Smoking habit (yes) | 57.46% (127/221) |
| Number of cigarettes per day | 7.60 (8.29) |
| Blood pressure medication (yes) | 15.38% (34/221) |
| Cholesterol or triglyceride medication (yes) | 9.95% (22/221) |
| Diabetes medication (yes) | 8.1% (18/221) |
| Disease duration (years) | 16.77 (9.96) |
| Self-reported Hurley | |
| I | 29.41% (65/221) |
| II | 38.91% (86/221) |
| III | 31.67% (70/221) |
| Self-referred disease activity | 5.51 (2.80) |
| Actual HS treatment | |
| Oral antibiotics | 17.19 (38/221) |
| Topical antibiotics | 19.00% (42/221) |
| Biologics | 30.31% (67/221) |
| None | 21.71% (48/221) |
| Systemic treatment different form antibiotics | 11.68% (26/221) |
| IHS4 (only patients from our HS Clinic, n = 57) | 11.31 (13.17) |
ASHENDI, Asociación de Enfermos de Hidrosadenitis; BMI, body mass index; HS, Hidradenitis Suppurativa; IHS4, International Hidradenitis Suppurativa Severity Score System. Data are expressed as the relative (absolute) frequencies and means (standard deviation (SD)).